| 产品名称： | Aspergillus alliaceus Thom et Church, anamorph |
|---|---|
| 商品货号： | TS172515 |
| Strain Designations： | MF4925 |
| Alternate State： | Petromyces alliaceus Malloch et Cain, teleomorph |
| Application： | produces asperlicin |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Type Strain： | no |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 200: YM agar or YM broth |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | Merck & Co., Inc. |
| U.S. Patent Number： | |
| Isolation： | derived from ATCC 20655 |
| References： | Goetz MA, et al. Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Fermentation, isolation and biological properties. J. Antibiot. 38: 1633-1637, 1985. PubMed: 3005212 Monaghan RL, et al. History of yield improvements in the production of asperlicin by Aspergillus alliaceus. J. Ind. Microbiol. 4: 97-104, 1989. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Aspergillus alliaceus Thom et Church, anamorph |
|---|---|
| 商品货号： | TS172515 |
| Strain Designations： | MF4925 |
| Alternate State： | Petromyces alliaceus Malloch et Cain, teleomorph |
| Application： | produces asperlicin |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Type Strain： | no |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 200: YM agar or YM broth |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | Merck & Co., Inc. |
| U.S. Patent Number： | |
| Isolation： | derived from ATCC 20655 |
| References： | Goetz MA, et al. Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Fermentation, isolation and biological properties. J. Antibiot. 38: 1633-1637, 1985. PubMed: 3005212 Monaghan RL, et al. History of yield improvements in the production of asperlicin by Aspergillus alliaceus. J. Ind. Microbiol. 4: 97-104, 1989. |
